What is the first-line treatment for GERD?
H2 receptor antagonists and H2 blocker therapy H2 receptor antagonists are the first-line agents for patients with mild to moderate symptoms and grades I-II esophagitis. Options include cimetidine (Tagamet), famotidine (Pepcid), and nizatidine (Axid).
What is the best initial treatment for GERD?
Lifestyle modifications and acid-suppressive therapy through the use of antacids, H2RAs, or PPIs remain first-line treatment options for the management of GERD despite limited supporting data.
Can GERD damage lungs?
Lung and throat problems — If stomach acid backs up into the throat, this can cause inflammation of the vocal cords, a sore throat, or a hoarse voice. The acid can also be inhaled into the lungs and cause pneumonia or asthma symptoms. Over time, acid in the lungs can lead to permanent lung damage.
Which treatment is best for GERD allopathy or homeopathy?
Dr Pankaj Aggarwal, senior homeopathy physician, says, “Homeopathy is way considered best when it comes to safe and sound treatment as it is devoid of any kind side effects or after as in allopath and indulges in to the recovery of the disease or ailment as in Ayurveda where you need many sessions to cure the disease.
What is the gold standard for treatment of patients who have GERD?
Ambulatory pH monitoring is generally considered the diagnostic gold standard for use in patients with GERD. In this study, a pH monitor is placed in the esophagus above the lower esophageal sphincter, and the pH is recorded at given moments in time.
What is the latest treatment for GERD?
The newest therapy is the transoral incisionless fundoplication (TIF). This is an incisionless fundoplication performed with an endoscope that is inserted through the mouth and into the stomach. Short-term results appear favorable in carefully selected patients; however, long-term studies have not yet been completed.
What is step down therapy for GERD?
Proton pump inhibitors (PPIs) are the first choice of therapy for most GERD patients with or without esophageal mucosal injury. Full dose PPI-first “step-down” therapy is superior to histamin-2-receptor antagonist (H2RA) or low dose PPI-first “step-up” strategy with regard to both efficacy and cost-effectiveness.
Are there any clinical trials for pulmonary embolism?
The SEATTLE II (A Prospective, Singe-arm, Multi-center Trial of EkoSonic (R) Endovascular System and Activase for Treatment of Acute Pulmonary Embolism) study, 48 was a single arm multi-center trial of UA-CDT that demonstrated improved right ventricular hemodynamic indices in patients undergoing UA-CDT for both massive and submassive PE.
How to diagnose PE in pulmonary embolism?
PE diagnosis. PE are visualized as filling defects (gray) in contrast-filled (white) pulmonary arteries and most often arise at sites of bifurcation or vessel narrowing. One of the largest diagnostic studies of CTPA for PE was the landmark PIOPED (Prospective Investigation of Pulmonary Embolism Diagnosis)-II study,…
Are there any devices to treat pulmonary embolism?
Emerging devices such as the FlowTriever System (Inari Medical, Irvine, CA) and the Indigo System (Penumbra Inc., Alameda, CA), which are specifically designed for use in patients with an absolute contraindication to thrombolytic therapy, currently remain only in investigational stages. 83
What are the ESC guidelines for pulmonary embolism?
2019 European Society of Cardiology (ESC) Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism, and include recommendations for the expanded use of direct oral anticoagulants (DOACs) for patients with cancer, recommendations to treat subsegmental and incidental PE in patients with cancer, and options for reduced dosing